The active substance in the composition of the drug ADENOPROSIN ® is a biomass obtained from the larvae of insects of the gypsy moth (Lymantria dispar), which has anti-inflammatory and antioxidant effects.
Biologically active components of the drug reduce the formation of phospholipase A2 and the release of arachidonic acid with a decrease in the synthesis of PG and LT (inhibit 5-lipoxygenase). The drug reduces capillary permeability, reduces prostate edema, improves microcirculation in the prostate gland.
The action of the drug ADENOPROSIN ® is manifested due to pathogenetic and nonspecific mechanisms. The drug ADENOPROSIN ® already in the first days after the start of use improves urodynamic parameters (increases the value of the maximum volumetric urine flow rate, decreases urination time, reduces the amount of residual urine) and the general condition of patients with BPH and chronic prostatitis (decreases the index of chronic prostatitis, the content of leukocytes in secret prostate, improves the homogeneity of its echo structure).
The drug regulates the tone and peristalsis of the lower segments of the urinary tract, reducing the frequency of urination, incl. at night, and reducing dysuria, feeling of incomplete emptying of the bladder and tension during urination. The antioxidant effect of the drug ADENOPROSIN ® is expressed by inhibition of lipid peroxidation due to the antioxidant water-soluble compounds of the drug.
benign prostatic hyperplasia;
chronic prostatitis (in combination therapy).
Recommendations for use
Rectally, 1 supp. 1 time per day (preferably at night at the same time).
The duration of treatment is from 1 to 3 months, depending on the intensity of inflammatory processes in the prostate and the severity of BPH symptoms, as well as their combination.
If necessary, the course of treatment can be repeated.
hypersensitivity to the components of the drug;
acute urinary retention;
malignant neoplasms of the prostate gland;
children under 18 years of age.
From the gastrointestinal tract: rarely – diarrhea or frequent stools; itching in the anal area.
Allergic reactions, general weakness are possible.
The drug should be used after a bowel movement or enema. It is recommended that the patient stay in the supine position for 30–40 minutes after the administration of the drug.
Influence on the ability to drive vehicles, mechanisms. Does not affect.
Do not use after the expiration date printed on the package.